A company dedicated to the treatment and supportive care of cancer and AIDS patients.

In cancer.in Transdrug : Significant increase in survival in patients advanced hepatocellular carcinoma advanced hepatocellular carcinoma in a Phase II clinical studyBioAlliance Pharma SA , a company dedicated to the treatment and supportive care of cancer and AIDS patients, announces positive survival data in the Phase II trial of doxorubicin Transdru in patients with advanced hepatocellular carcinoma .

– BioAlliance Pharma based on its proprietary Transdru nanotechnology by developing oral dosage forms capitalize, said Dominique Costantini, President and CEO of BioAlliance Pharma. We apply this innovative know-how in the treatment of various cancers with oral irinotecan nanoparticles instead of intravenously administration. BioAlliance Pharma aims at improving the irinotecan the risk-benefit ratio and positive preclinical data positive preclinical data at several international symposia , added Dominique Costantini..Most individuals find it much shocking that the combination of salivary and smoking is actually more of fatal cells in the mouth than cigarette smoke itself Esaid study co-author Dr. Rafi Nagler? Our study shows soon as are exposed the cigarette smoke, of our normally healthy salivary loses not only its positive qualities which but it turns traitors and indeed helps in destruction of cells of the mouths and oral cavity. Tobacco smoke is not only harmful on its own, it can sweep body against itself.

Related Posts

Other Posts From Category "obstetrics":